InvestorsHub Logo
Post# of 316925
Next 10
Followers 363
Posts 113982
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Tuesday, 06/27/2017 12:33:43 PM

Tuesday, June 27, 2017 12:33:43 PM

Post# of 316925
ALDR anyone? A migraine treatment developed by Washington-based Alder Biopharmaceuticals appeared to deliver less of a benefit over placebo than rival drugs, sending shares in the biotech down more than 20% in early Tuesday trading even though the Phase 3 study met its goal.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.